Ranbaxy Laboratories Ltd is the largest pharmaceutical company in India with FDA inspected and approved facilities. It has expertise in diverse product categories including OTC drugs. Some key events in its history include establishing its first joint venture in Nigeria in 1977 and receiving FDA approval for its API facility in India in 1988, allowing it to enter the US market. In more recent years, it has made acquisitions to expand its international business, including buying businesses in Germany, France, and the United States. Currently, it is seeking to acquire a $2 billion stake in Merck to continue growing its global operations.